Bioventus Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2024 | 1 | $0.07 | $0.07 | $0.07 |
| Q3 2024 | 1 | $0.02 | $0.02 | $0.02 |
| Q4 2024 | 2 | $0.08 | $0.08 | $0.08 |
| Q1 2025 | 2 | $0.05 | $0.10 | $0.07 |
| Q2 2025 | 1 | $0.24 | $0.24 | $0.24 |
| Q3 2025 | 1 | $0.20 | $0.20 | $0.20 |
| Q4 2025 | 1 | $0.24 | $0.24 | $0.24 |
Bioventus Inc. Earnings Date And Information
Bioventus Inc. last posted its earnings results on Tuesday, November 5th, 2024. The company reported $0.06 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by $0. The company had revenue of 138.96 M for the quarter and had revenue of 512.35 M for the year. Bioventus Inc. has generated $-2 earnings per share over the last year ($-2.49 diluted earnings per share) and currently has a price-to-earnings ratio of -18.59. Bioventus Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based on prior year's report dates.
Bioventus Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/05/2024 | Q3 2024 | $0.06 | -$0.07 | -0.13 | $133.24 M | $138.96 M |
| 08/06/2024 | Q2 2024 | $0.07 | -$0.37 | -0.44 | $151.22 M | |
| 05/07/2024 | Q1 2024 | -$0.05 | -$0.07 | -0.02 | $129.46 M | |
| 03/12/2024 | Q4 2023 | $0.06 | -$0.10 | -0.16 | $135.42 M | |
| 11/07/2023 | Q3 2023 | $0.06 | -$0.12 | -0.18 | $120.79 M | |
| 08/08/2023 | Q2 2023 | $0.03 | -$0.06 | -0.09 | $137.07 M | |
| 05/16/2023 | Q1 2023 | -$0.11 | -$1.61 | -1.5 | $119.06 M | |
| 03/31/2023 | Q4 2022 | -$0.72 | $125.83 M | |||
| 11/21/2022 | Q3 2022 | $0.13 | -$1.18 | -1.31 | $128.66 M | |
| 08/12/2022 | Q2 2022 | -$0.13 | $140.33 M | |||
| 05/11/2022 | Q1 2022 | -$0.24 | $117.29 M | |||
| 03/11/2022 | Q4 2021 | -$0.01 | $130.41 M | |||
| 11/10/2021 | Q3 2021 | -$0.03 | $108.89 M | |||
| 08/11/2021 | Q2 2021 | -$0.10 | $109.82 M | |||
| 05/13/2021 | Q1 2021 | $0.60 | $81.78 M | |||
| 03/26/2021 | Q4 2020 | $0.07 | $98.59 M | |||
| 09/30/2020 | Q3 2020 | $0.15 | $85.91 M | |||
| 06/30/2020 | Q2 2020 | -$0.10 | $58.02 M | |||
| 03/31/2020 | Q1 2020 | $0.20 | $78.65 M | |||
| 12/31/2019 | Q4 2019 | $0.10 | $97.55 M |
Bioventus Inc. Earnings: Frequently Asked Questions
-
When is Bioventus Inc.'s earnings date?
Bioventus Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based off last year's report dates.
-
How can I listen to Bioventus Inc.'s earnings conference call?
The conference call for Bioventus Inc.'s latest earnings report can be listened to online.
-
How can I read Bioventus Inc.'s conference call transcript?
The conference call transcript for Bioventus Inc.'s latest earnings report can be read online.
-
How much revenue does Bioventus Inc. generate each year?
Bioventus Inc. (:BVS) has a recorded annual revenue of $512.35 M.
-
How much profit does Bioventus Inc. generate each year?
Bioventus Inc. (:BVS) has a recorded net income of $512.35 M. Bioventus Inc. has generated $-2.49 earnings per share over the last four quarters.
-
What is Bioventus Inc.'s price-to-earnings ratio?
Bioventus Inc. (:BVS) has a price-to-earnings ratio of -18.59 and price/earnings-to-growth ratio is -2.45.
